Perrigo Company plc (PRGO)
- Previous Close
33.06 - Open
33.34 - Bid 32.50 x 800
- Ask 33.00 x 3200
- Day's Range
32.56 - 33.35 - 52 Week Range
25.77 - 40.28 - Volume
963,189 - Avg. Volume
1,935,700 - Market Cap (intraday)
4.444B - Beta (5Y Monthly) 0.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.03 - Earnings Date May 7, 2024
- Forward Dividend & Yield 1.10 (3.37%)
- Ex-Dividend Date May 31, 2024
- 1y Target Est
40.50
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
www.perrigo.com9,140
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PRGO
Performance Overview: PRGO
Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRGO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRGO
Valuation Measures
Market Cap
4.44B
Enterprise Value
7.77B
Trailing P/E
--
Forward P/E
12.80
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.95
Price/Book (mrq)
0.93
Enterprise Value/Revenue
1.67
Enterprise Value/EBITDA
14.79
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.27%
Return on Assets (ttm)
1.64%
Return on Equity (ttm)
-0.09%
Revenue (ttm)
4.66B
Net Income Avi to Common (ttm)
-4.4M
Diluted EPS (ttm)
-0.03
Balance Sheet and Cash Flow
Total Cash (mrq)
744.4M
Total Debt/Equity (mrq)
89.60%
Levered Free Cash Flow (ttm)
498.94M
Research Analysis: PRGO
Company Insights: PRGO
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: PRGO
Market Update: OKE, PRGO, UNH
Stocks rose on Thursday as investors digested new data. Initial jobless claims were 221,000 for the week ending March 30, up from last week's revised 212,000 and above expectations. Ongoing unemployment declined to 1,791,000 from the previous week's revised 1,810,000. The U.S. trade deficit was $68.9 billion in February, an increase of 1.9% from January. Exports of goods increased $5.0 billion, led by aircraft (+$1.4 billion) and crude oil (+$1.1 billion), while exports of passenger vehicles declined $0.9 billion. Imports of goods rose $4.7 billion, led by cell phones and household goods (+1.4 billion) foods, feeds and beverages ($1.3 billion), and automobiles and parts (+1.1 billion). The Dow was up 0.4%, the S&P 500 rose 0.7% and the Nasdaq gained 0.9%. Crude oil traded above $85 per barrel, while gold traded near $2313 per ounce.
Analyst Report: Perrigo Company PLC
Perrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo's private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has over 9,000 employees.
RatingPrice TargetMarket Update: OKE, PRGO, UNH
Stocks rose on Thursday as investors digested new data. Initial jobless claims were 221,000 for the week ending March 30, up from last week's revised 212,000 and above expectations. Ongoing unemployment declined to 1,791,000 from the previous week's revised 1,810,000. The U.S. trade deficit was $68.9 billion in February, an increase of 1.9% from January. Exports of goods increased $5.0 billion, led by aircraft (+$1.4 billion) and crude oil (+$1.1 billion), while exports of passenger vehicles declined $0.9 billion. Imports of goods rose $4.7 billion, led by cell phones and household goods (+1.4 billion) foods, feeds and beverages ($1.3 billion), and automobiles and parts (+1.1 billion). The Dow was up 0.4%, the S&P 500 rose 0.7% and the Nasdaq gained 0.9%. Crude oil traded above $85 per barrel, while gold traded near $2313 per ounce.
The Argus Mid-Cap Model Portfolio
Small- and mid-cap stocks (SMID) have underperformed large-caps over the past 12 months, but may be in a better position to generate market-beating returns going forward. SMID companies tend to focus on domestic markets, so their businesses could be less disrupted by the fallout from global events. As well, the prices of SMID stocks generally are lower than the prices of large-caps. As well, there are long stretches in the record books when SMID stocks have outperformed large-caps. That said, SMID stocks can be risky. The standard deviation for monthly returns was 5.7% for SMID stocks over a 2003-2021 test period, versus 4.3% for large-caps. Still, despite the risks, diversified investors look to have exposure to small- and mid-caps based on the long-term performance record.